This study aimed at correlating maternal blood glucose levels with DNA damage levels in the offspring of women with diabetes or mild gestational hyperglycemia (MGH).
Methodology:
Based on oral glucose tolerance test results and glycemic profiles, 56 pregnant women were allocated into 3 groups: nondiabetes, MGH, and diabetes. The offspring of these women (56 infants) were also evaluated. Maternal peripheral blood and umbilical cord blood samples were collected and processed for biochemical and DNA damage analysis by the comet assay.
Results:
A positive correlation between maternal blood glucose mean and increased offspring DNA damage levels was observed. Hyperglycemia played a role in offspring DNA damage, but other diabetes-induced complications were also involved.
Conclusion:
Increased maternal blood glucose levels can lead to increased offspring DNA damage levels. Therefore, the monitoring, control, and treatment of pregnant women with diabetes and MGH are highly important to ensure a risk-free pregnancy and healthy infants.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(suppl 1):S81–S90.
2.
MetzgerBECoustanDR.The organizing committee. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 1998;21(suppl 2):B161–B167.
3.
KöckKKöckFKleinKBancher-TodescaDHelmerH. Diabetes mellitus and the risk of preterm birth with regard to the risk of spontaneous preterm birth. J Matern Fetal Neonatal Med. 2010;23(9):1004–1008.
4.
RudgeMVCalderonIMRamosMDAbbadeJFRugoloLM. Perinatal outcome of pregnancies complicated by diabetes and maternal daily hyperglycemia not related to diabetes. A retrospective 10-year analysis. Gynecol Obstet Invest. 2000;50(2):108–112.
5.
NegratoCAJovanovicLTambasciaMA. Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Diabetes Metab Res Rev. 2008;24(4):324–330.
6.
SilvaMRGCalderonIMPGonçalvesLCAragonFFPadovaniCRPimentaWP. Ocorrência de diabetes melito em mulheres com hiperglicemia em gestação prévia. Rev Saúde Pública. 2003;37(3):345–350.
7.
RudgeMVCCalderonIMPRamosMDSuetakeHPeraçoliJC. Investigação diagnóstica do diabetes na gestação. Rev Bras Ginecol Obst. 1996;18:21–26.
8.
RudgeMVCCalderonIMPRamosMD. Hiperglicemia materna diária diagnosticada pelo perfil glicêmico: um problema de saúde pública materno e perinatal. Rev Bras Ginecol Obstet. 2005;27(11):691–697.
9.
DinçerYAkçayTIlkovaHAlademirZOzbayG. DNA damage and antioxidant defense in peripheral leukocytes of patients with type 1 diabetes mellitus. Mutat Res. 2003;527(1-2):49–55.
10.
PitozziVGiovannelliLBardiniGRotellaCMDolaraP. Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: higher vulnerability of polymorphonuclear leukocytes. Mutat Res. 2003;28(1-2):129–133.
11.
AndersonDYuTWrightJIoannidesC. An examination of DNA strand breakage in the comet assay and antioxidant capacity in diabetic patients. Mutat Res. 1998;398(1-2):151–161.
12.
LimaPHOSinzatoYKGelaletiRB. Genotoxicity evaluation in severe or mild diabetic pregnancy in laboratory animals. Exp Clin Endocrinol Diabetes. 2012;119(7):408–413.
13.
GilmerMDGBeardRWBrookeFMOakleyNW. Carbohydrate metabolism in pregnancy. Part I. Diurnal plasma glucose profile in normal and diabetic women. Br Med J. 1975;3(5980):399–402.
14.
RudgeMVCCalderonIMPRamosMD. Perspectiva perinatal decorrente do rígido controle pré-natal em gestações complicadas pelo diabete. RBGO. 1995;17:26–32.
15.
CollinsARRaslováKSmorovskáMP. DNA damage in diabetes: correlation with a clinical marker. Free Rad Biol Med. 1998;25(3):373–377.
16.
BlasiakJArabskiMKrupaR. DNA damage and repair in type 2 diabetes mellitus. Mutat Res. 2004;554(1-2):297–304.
17.
DandonaPThusuKCookS. Oxidative damage to DNA in diabetes mellitus. Lancet. 1996;347(8999):444–445.
18.
MoreiraROCamposSCSolderaAL. Type 2 diabetes mellitus and Alzheimer’s disease: from physiopathology to treatment implications[published online ahead of print July 18, 2013]. Diabetes Metab Res Rev. doi: 10.1002/dmrr/2442.
19.
GelaletiRBDamascenoDCLimaPHO. Oxidative DNA damage in diabetic and mild gestational hyperglycemic pregnant women. Diabetol Metab Syndrome. 2015;7:1.
20.
MandalDMandaSRakshiADeyRPBiswasSCBanerjeeA. Maternal obesity and pregnancy outcome: a prospective analysis. J Assoc Physicians India. 2011;59:486–489.
21.
Bautista-CastañoIHenriquez-SanchezPAlemán-PerezN. Maternal obesity in early pregnancy and risk of adverse outcomes. PLoS One. 2013;8(11):e80410.
22.
EslamianLAkbariSMarsoosiVJamalA. Effect of different maternal metabolic characteristics on fetal growth in women with gestational diabetes mellitus. Iran J Reprod Med. 2013;11(4):325–334.
23.
SonGHKwonJYKimYHParkYW. Maternal serum triglycerides as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus. Acta Obstet Gynecol Scand. 2010;89(5):700–704.
24.
SarikabadayiYUAydemirOAydemirC. Umbilical cord oxidative stress in infants of diabetic mothers and its relation to maternal hyperglycemia. J Pediatr Endocrinol Metab. 2011;24(9-10):671–674.
25.
Van LeeuwenMPrinsSMde ValkHWEversIMVisserGHMolBW. Gestational diabetes mellitus: treatment reduces the risk of complications. Ned Tijdschr Geneeskd. 2011;155:A2291.
26.
BukhariSARajokaMINagraSARehmanZU. Plasma homocysteine and DNA damage profiles in normal and obese subjects in the Pakistani population. Mol Biol Rep. 2010;37(1):289–295.
27.
YildizAGürMYilmazR. Lymphocyte DNA damage and total antioxidant status in patients with white-coat hypertension and sustained hypertension. Turk Kardiyol Dern Ars. 2008;36(4):231–238.
28.
MinaminoTOrimoMShimizuI. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med. 2009;15(9):1082–1987.
29.
GürMElbasanZYıldıray ŞahinD. DNA damage and oxidative status in newly diagnosed, untreated, dipper and non-dipper hypertensive patients. Hypertens Res. 2013;36(2):166–171.
30.
SongFJiaWYaoY. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. Clin Sci. 2007;112(12):599–606.
